We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Europe Leading on Biogenerics, But Pathway Questions Remain
Europe Leading on Biogenerics, But Pathway Questions Remain
May 20, 2005
The European Union (EU) is outpacing the U.S. in establishing an approval pathway for follow-on biologics, but some EU industry observers warn that the regulatory waters remain murky.